In line with the observations mentioned above (Fig. 3), these analyses confirmed that the enhanced myeloid differentiation, in companion of the suppressed LSC program but not the enhanced apoptosis and cell cycle arrest, represented the major effector pathways of JMJD3 overexpression in AML cells. This evidence concerns the gene KDM6B and acute myeloid leukemia.